Loomis, Sayles & Company
CVS icon

Loomis, Sayles & Company’s CVS Health CVS Stock Holding History

Loomis, Sayles & Company’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$143K Buy
1,381
+767
+125% +$68.5K ﹤0.01% 566
2026
Q1 		$44.1K Sell
614
-747
-55% -$57.5K ﹤0.01% 620
2025
Q4 		$108K Buy
1,361
+17
+1% +$1.34K ﹤0.01% 571
2025
Q3 		$101K Sell
1,344
-330
-20% -$22.6K ﹤0.01% 562
2025
Q2 		$115K Buy
1,674
+166
+11% +$10.9K ﹤0.01% 551
2025
Q1 		$102K Buy
1,508
+656
+77% +$39.3K ﹤0.01% 571
2024
Q4 		$38K Sell
852
-1,350
-61% -$75.7K ﹤0.01% 683
2024
Q3 		$138K Buy
2,202
+141
+7% +$8.23K ﹤0.01% 527
2024
Q2 		$122K Sell
2,061
-60
-3% -$3.75K ﹤0.01% 540
2024
Q1 		$169K Sell
2,121
-568
-21% -$43.4K ﹤0.01% 523
2023
Q4 		$212K Sell
2,689
-38
-1% -$2.71K ﹤0.01% 503
2023
Q3 		$190K Sell
2,727
-3,507
-56% -$248K ﹤0.01% 507
2023
Q2 		$431K Buy
6,234
+1,574
+34% +$112K ﹤0.01% 487
2023
Q1 		$346K Sell
4,660
-78
-2% -$6.54K ﹤0.01% 488
2022
Q4 		$442K Buy
4,738
+2,061
+77% +$199K ﹤0.01% 457
2022
Q3 		$255K Sell
2,677
-515
-16% -$51K ﹤0.01% 453
2022
Q2 		$296K Sell
3,192
-8,883
-74% -$867K ﹤0.01% 474
2022
Q1 		$1.22M Buy
12,075
+11,785
+4,064% +$1.24M ﹤0.01% 448
2021
Q4 		$30K Sell
290
-164
-36% -$15.2K ﹤0.01% 640
2021
Q3 		$39K Buy
454
+1
+0.2% +$84 ﹤0.01% 614
2021
Q2 		$38K Sell
453
-67,387
-99% -$5.52M ﹤0.01% 599
2021
Q1 		$5.1M Sell
67,840
-1,097
-2% -$79.9K 0.01% 420
2020
Q4 		$4.71M Buy
68,937
+51,302
+291% +$3.34M 0.01% 423
2020
Q3 		$1.03M Buy
17,635
+898
+5% +$55.9K ﹤0.01% 445
2020
Q2 		$1.09M Sell
16,737
-27
-0.2% -$1.7K ﹤0.01% 446
2020
Q1 		$995K Buy
16,764
+14,504
+642% +$968K ﹤0.01% 456
2019
Q4 		$168K Buy
2,260
+198
+10% +$13.9K ﹤0.01% 541
2019
Q3 		$130K Buy
+2,062
New +$122K ﹤0.01% 531
2019
Q1 		– Sell
-35,263
Closed -$2.31M – 793
2018
Q4 		$2.31M Buy
35,263
+2,965
+9% +$221K 0.01% 484
2018
Q3 		$2.54M Sell
32,298
-111,402
-78% -$7.96M 0.01% 525
2018
Q2 		$9.25M Sell
143,700
-54,502
-27% -$3.59M 0.02% 439
2018
Q1 		$12.3M Buy
198,202
+64,061
+48% +$4.6M 0.03% 377
2017
Q4 		$9.72M Sell
134,141
-132,120
-50% -$9.61M 0.02% 445
2017
Q3 		$21.7M Sell
266,261
-99,863
-27% -$7.9M 0.05% 258
2017
Q2 		$29.5M Sell
366,124
-557,678
-60% -$44M 0.07% 173
2017
Q1 		$72.5M Sell
923,802
-618,151
-40% -$49.3M 0.18% 67
2016
Q4 		$122M Sell
1,541,953
-46,193
-3% -$3.74M 0.3% 47
2016
Q3 		$141M Buy
1,588,146
+711,383
+81% +$67.1M 0.36% 39
2016
Q2 		$83.9M Buy
876,763
+1,423
+0.2% +$142K 0.23% 54
2016
Q1 		$90.8M Sell
875,340
-32,240
-4% -$3.13M 0.26% 51
2015
Q4 		$88.7M Buy
907,580
+112,699
+14% +$11M 0.25% 56
2015
Q3 		$76.7M Sell
794,881
-21,095
-3% -$2.22M 0.23% 67
2015
Q2 		$85.6M Sell
815,976
-99,170
-11% -$10.1M 0.23% 72
2015
Q1 		$94.5M Sell
915,146
-186,572
-17% -$18.9M 0.26% 68
2014
Q4 		$106M Sell
1,101,718
-221,945
-17% -$19.6M 0.29% 59
2014
Q3 		$105M Sell
1,323,663
-167,269
-11% -$13.2M 0.31% 65
2014
Q2 		$112M Sell
1,490,932
-142,534
-9% -$10.8M 0.32% 68
2014
Q1 		$122M Buy
1,633,466
+66,920
+4% +$4.73M 0.35% 64
2013
Q4 		$112M Buy
1,566,546
+94,416
+6% +$6.07M 0.34% 69
2013
Q3 		$83.5M Sell
1,472,130
-509,714
-26% -$30.4M 0.27% 94
2013
Q2 		$113K Buy
+1,981,844
New +$115M 0.4% 49

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Loomis, Sayles & Company's CVS Position: Q2 2026 in Review

Loomis, Sayles & Company increased its CVS Health (CVS) stake by 125% in Q2 2026, buying an estimated $68.5K and bringing the position to 1,381 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #566.

Loomis, Sayles & Company first reported a position in CVS in Q2 2013 and has held it in 51 quarters since. The position peaked at $141M in Q3 2016. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Loomis, Sayles & Company held 1,381 shares of CVS Health worth $143K as of Q2 2026.
  • Loomis, Sayles & Company bought 767 CVS Health shares in Q2 2026, an estimated $68.5K.
  • CVS Health made up ﹤0.01% of Loomis, Sayles & Company's portfolio in Q2 2026, its #566 holding.
  • Loomis, Sayles & Company first reported a position in CVS Health in Q2 2013 and has held it in 51 quarters since.
  • Loomis, Sayles & Company's CVS Health position peaked at $141M in Q3 2016.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.